- Home
- BRNS
as 05-15-2025 4:00pm EST
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
| Founded: | 2016 | Country: | United Kingdom |
| Employees: | N/A | City: | DIDCOT |
| Market Cap: | 38.7M | IPO Year: | 2021 |
| Target Price: | $3.00 | AVG Volume (30 days): | 33.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.64 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.64 - $2.45 | Next Earning Date: | 05-07-2025 |
| Revenue: | $14,969,000 | Revenue Growth: | 4381.74% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Barinthus Biotherapeutics plc News
BRNS Breaking Stock News: Dive into BRNS Ticker-Specific Updates for Smart Investing
GlobeNewswire
8 days ago
Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments
Simply Wall St.
19 days ago
Here's Why We're Not Too Worried About Barinthus Biotherapeutics' (NASDAQ:BRNS) Cash Burn Situation
GlobeNewswire
2 months ago
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
ACCESS Newswire
2 months ago
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
ACCESS Newswire
2 months ago
Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11
Simply Wall St.
3 months ago
US Exchange Insights: 3 Penny Stocks With Over $40M Market Cap
GlobeNewswire
4 months ago
Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update
Simply Wall St.
5 months ago
Edesa Biotech And 2 Other Promising US Penny Stocks For Your Radar
Compare BRNS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BRNS Barinthus Biotherapeutics plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.